Pharmacokinetic evaluation of para-aminosalicylic acid granules.

Abstract:

STUDY OBJECTIVE:To determine the bioavailability and renal elimination of para-aminosalicylic acid (PAS) and its inactive metabolite acetyl-para-aminosalicylic acid (AcPAS) from a new PAS formulation. DESIGN:(a) Single-dose pharmacokinetic study in healthy volunteers; (b) Day-1 and day-8 pharmacokinetic comparison in patients with multidrug-resistant tuberculosis (MDR-TB). SETTING:Referral hospital that specializes in the treatment of mycobacterial infections. PATIENTS:(a) Twelve healthy male and female volunteers recruited by the investigators. Eleven subjects (92%) completed the study; one subject could not maintain venous access and was removed from the study. (b) Six sequential male and female patients receiving multidrug treatment for advanced MDR-TB. All patients completed the study. INTERVENTIONS:(a) Volunteers received a single 4-g dose of enteric-coated PAS granules administered with food. Blood and urine samples were collected over 24 hours after the dose. (b) Patients received 4-g doses of enteric-coated PAS granules every 8 hours for 7 days as part of their treatment regimen. Blood samples were obtained at approximately 2, 4, and 8 hours after the first dose on day 1 and the twenty-second dose on day 8. MEASUREMENTS AND MAIN RESULTS:Concentrations of PAS and AcPAS were determined using high-performance liquid chromatography. The serum concentration-time curves from volunteers and patients showed sustained PAS concentrations, in contrast to immediate-release sodium PAS tablets. In the six patients with tuberculosis, day 8 concentrations were considerably higher than those on day 1, and all were sustained well above the PAS minimal inhibitory concentration for Mycobacterium tuberculosis. CONCLUSIONS:Para-aminosalicylic acid granules produce adequate serum concentrations and appear to be safe.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Peloquin CA,Henshaw TL,Huitt GA,Berning SE,Nitta AT,James GT

doi

10.1002/j.1875-9114.1994.tb02787.x

subject

Has Abstract

pub_date

1994-01-01 00:00:00

pages

40-6

issue

1

eissn

0277-0008

issn

1875-9114

journal_volume

14

pub_type

临床试验,杂志文章
  • Novel oral anticoagulants and their role in clinical practice.

    abstract::The complexities of oral anticoagulation with warfarin have led to the search for more practical alternative agents. Novel direct factor IIa inhibitors and direct factor Xa inhibitors currently in development can be administered at a fixed dose and do not require routine coagulation monitoring and ongoing dosage adjus...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.12.1175

    authors: Wittkowsky AK

    更新日期:2011-12-01 00:00:00

  • Expanding Opportunities in the Postacute Long-Term Care Setting: Bringing Medication Safety to the Next Level.

    abstract::Skilled nursing facilities and nursing homes are care settings that offer increasing opportunities for pharmacists to take the lead when addressing the new updated Centers for Medicare and Medicaid Services (CMS) requirements coupled with enhanced quality measures reporting. In addition, the complexity of the medicati...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2155

    authors: Brandt NJ,Worz C,Clackum SF

    更新日期:2018-08-01 00:00:00

  • Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide.

    abstract::A 64-year-old woman receiving intravenous chemotherapy for stage IIIB non-small cell lung cancer experienced acute arterial thrombosis of the distal radial and entire ulnar arteries with subsequent arterial occlusion of the right popliteal artery. Two separate arterial occlusions occurred after administration of cispl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.13.1200.33524

    authors: Cool RM,Herrington JD,Wong L

    更新日期:2002-09-01 00:00:00

  • Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.

    abstract::Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, complex, idiosyncratic drug reaction that can be fatal. Systemic symptoms include lymphadenopathy, hepatic failure, and possibly renal failure. The syndrome has been primarily associated with anticonvulsants, whereas antimicrobials are less ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1142

    authors: Miller Quidley A,Bookstaver PB,Gainey AB,Gainey MD

    更新日期:2012-12-01 00:00:00

  • Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies.

    abstract:STUDY OBJECTIVE:To assess the pharmacokinetic profile of palifermin after intravenous dosing with either a collapsed dose of 180 microg/kg/day for 1 day or a standard dose of 60 microg/kg/day for 3 days, before and after myeloablative chemoradiotherapy and peripheral blood progenitor cell (PBPC) transplantation. DESIG...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.27.10.1353

    authors: Zia-Amirhosseini P,Hurd DD,Salfi M,Cheah TC,Aycock J,Cesano A

    更新日期:2007-10-01 00:00:00

  • Effect of sustained endotoxemia on alpha1-adrenergic responsiveness in parenterally fed rats.

    abstract::We investigated the effect of endotoxemia on alpha1-adrenergic receptor-mediated smooth muscle contraction as measured by mean arterial pressure (MAP) in response to incremental doses of a vasopressor. Twelve male Sprague-Dawley rats were randomized to receive parenteral nutrition alone (PN) or in combination with a c...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Dickerson RN,Lima JJ,Kuhl DA,Brown RO,Hak LJ

    更新日期:1998-01-01 00:00:00

  • Emerging roles for pharmacists in clinical implementation of pharmacogenomics.

    abstract::Pharmacists are uniquely qualified to play essential roles in the clinical implementation of pharmacogenomics. However, specific responsibilities and resources needed for these roles have not been defined. We describe roles for pharmacists that emerged in the clinical implementation of genotype-guided clopidogrel ther...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1481

    authors: Owusu-Obeng A,Weitzel KW,Hatton RC,Staley BJ,Ashton J,Cooper-Dehoff RM,Johnson JA

    更新日期:2014-10-01 00:00:00

  • Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy.

    abstract::Idiopathic recurrent pericarditis (IRP) can be challenging to treat. Even after guideline-directed first-line treatment consisting of aspirin (ASA) or a nonsteroidal antiinflammatory drug (NSAID) in combination with colchicine therapy, recurrences still occur in greater than 20% of patients. Many patients then require...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1897

    authors: Schwier NC,Hale GM,Davies ML

    更新日期:2017-03-01 00:00:00

  • Viral infectivity of albumin and plasma protein fraction.

    abstract::Original research, reviews, and case reports discussing viral infectivity of blood- and plasma-derived products were reviewed to determine the potential viral infectivity of human serum albumin (HSA) and plasma protein fraction (PPF). Data concerning viral infectivity viral screening and inactivation procedures, and v...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Erstad BL

    更新日期:1996-11-01 00:00:00

  • Acute care clinical pharmacy practice: unit- versus service-based models.

    abstract::This commentary from the 2010 Task Force on Acute Care Practice Model of the American College of Clinical Pharmacy was developed to compare and contrast the "unit-based" and "service-based" orientation of the clinical pharmacist within an acute care pharmacy practice model and to offer an informed opinion concerning w...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/PHAR.1042

    authors: American College of Clinical Pharmacy.,Haas CE,Eckel S,Arif S,Beringer PM,Blake EW,Lardieri AB,Lobo BL,Mercer JM,Moye P,Orlando PL,Wargo K

    更新日期:2012-02-01 00:00:00

  • Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

    abstract::The era of the integrase strand transfer inhibitors (INSTIs) for the treatment of human immunodeficiency virus (HIV) infection began with raltegravir in 2007. Since that time, several other INSTIs have been introduced including elvitegravir, dolutegravir, and, most recently, bictegravir, that have shown great utility ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2246

    authors: Brooks KM,Sherman EM,Egelund EF,Brotherton A,Durham S,Badowski ME,Cluck DB

    更新日期:2019-05-01 00:00:00

  • The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.

    abstract:STUDY OBJECTIVE:To evaluate the safety, tolerability, and pharmacokinetic profile of fosphenytoin, a water-soluble phenytoin prodrug, after intramuscular and intravenous administration. DESIGN:Open-label study of intramuscular administration, and double-blind, randomized study of intravenous administration. SETTING:S...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Boucher BA,Feler CA,Dean JC,Michie DD,Tipton BK,Smith KR Jr,Kramer RE,Young B,Parks BR Jr,Kugler AR

    更新日期:1996-07-01 00:00:00

  • Prescribing patterns and outcomes of enoxaparin for anticoagulation of atrial fibrillation.

    abstract:STUDY OBJECTIVE:To determine prescribing patterns and clinical outcomes of enoxaparin for anticoagulation of atrial fibrillation. DESIGN:Retrospective analysis. SETTING:A 650-bed, tertiary care, community teaching hospital. SUBJECTS:Two hundred thirteen patients who received enoxaparin for thromboprophylaxis during ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.23.5.651.32208

    authors: Khazan M,Scheuering S,Adamson R,Mathis AS

    更新日期:2003-05-01 00:00:00

  • Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.

    abstract:STUDY OBJECTIVE:To describe the population pharmacokinetics and pharmacodynamic target attainment of ampicillin in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing controlled hypothermia (CH). DESIGN:Prospective, open-label pharmacokinetic study. SETTING:A 189-bed, freestanding children's tertiary care ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1916

    authors: Cies JJ,Fugarolas KN,Moore WS 2nd,Mason RW,Menkiti OR

    更新日期:2017-04-01 00:00:00

  • Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.

    abstract::Infections caused by multidrug-resistant Acinetobacter baumannii have become a therapeutic challenge for clinicians worldwide. Although colistin and tigecycline have been successful in treating patients with these infections, these agents are not available on a worldwide basis. We describe four critically ill patients...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.11.1506

    authors: Lee NY,Wang CL,Chuang YC,Yu WL,Lee HC,Chang CM,Wang LR,Ko WC

    更新日期:2007-11-01 00:00:00

  • Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data.

    abstract:BACKGROUND:Opioid prescribing by dentists for older patients receiving medications with potential contraindications and the subsequent impact on acute care outcomes is not well described. OBJECTIVES:Our objective of this paper was to evaluate the use of potentially inappropriate medication combinations (PIMCs) involvi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2452

    authors: Zhou J,Calip GS,Rowan S,McGregor JC,Perez RI,Evans CT,Gellad WF,Suda KJ

    更新日期:2020-10-01 00:00:00

  • Tissue plasminogen activator: an evaluation of clinical efficacy in acute myocardial infarction.

    abstract::Recombinant tissue plasminogen activator (t-PA) is a synthetic fibrinolytic protein which activates plasminogen or converts plasminogen to plasmin specifically in the presence of fibrin. With its "clot-selectivity", t-PA is capable of lysing clots without having a significant effect on circulating plasminogen. In cont...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04035.x

    authors: Rogers SD,Riemersma LB,Clements SD

    更新日期:1987-01-01 00:00:00

  • Simvastatin-associated memory loss.

    abstract::The statins are widely used to treat dyslipidemias. They are generally associated with mild adverse effects, but rarely, more serious reactions may occur. A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was switched to pravastatin, ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.7.767.34577

    authors: Orsi A,Sherman O,Woldeselassie Z

    更新日期:2001-06-01 00:00:00

  • Postoperative atrial fibrillation: role of inflammatory biomarkers and use of colchicine for its prevention.

    abstract::Postoperative atrial fibrillation (POAF) is the most common complication following cardiac surgery, occurring in up to 65% of cardiac surgical patients. It is a condition associated with increased morbidity, increased length of hospital stay, and increased health care costs. One of the many potential causes of POAF is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1485

    authors: Worden JC,Asare K

    更新日期:2014-11-01 00:00:00

  • QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.

    abstract::Torsades de pointes is a polymorphic ventricular tachycardia characterized by marked QT prolongation on the electrocardiogram. It can be induced by both antiarrhythmic and nonantiarrhythmic drugs, such as quinidine and erythromycin. No extensive literature documents an interaction between quinidine and erythromycin wh...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Lin JC,Quasny HA

    更新日期:1997-05-01 00:00:00

  • Interpreting meta-analyses of pharmacologic interventions: the pitfalls and how to identify them.

    abstract::Meta-analyses are key components of evidence-based decision making. The numbers of meta-analyses published in different areas of health care increased dramatically during the past 10 years. Many of them covered different pharmacologic interventions, making them useful resources to clinical pharmacists. Although a well...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.9.741.31541

    authors: Etminan M,Levine M

    更新日期:1999-06-01 00:00:00

  • Nonhormonal alternatives for the treatment of hot flashes.

    abstract:OBJECTIVE:To review the literature on clonidine, venlafaxine, selective serotonin reuptake inhibitors, and gabapentin for the treatment of hot flashes. DATA SOURCES:A MEDLINE search (January 1966-July 2003) was conducted to identify English-language literature available on the treatment of hot flashes that focused on ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.1.79.34812

    authors: Sicat BL,Brokaw DK

    更新日期:2004-01-01 00:00:00

  • Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.

    abstract::Bedaquiline is a diarylquinoline antitubercular drug with a novel mechanism of action against Mycobacterium tuberculosis. Bedaquiline works by inhibiting bacterial adenosine triphosphate (ATP) synthase and represents the first novel class of antituberculosis agents in more than 40 years. Bedaquiline is indicated for t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1482

    authors: Worley MV,Estrada SJ

    更新日期:2014-11-01 00:00:00

  • Spontaneous Hemopericardium in a Patient Receiving Apixaban Therapy: First Case Report.

    abstract::Apixaban, a direct factor Xa inhibitor, is a novel oral anticoagulant (NOAC) indicated for prevention of embolic events in patients with nonvalvular atrial fibrillation. The agent is associated with a lower risk of bleeding compared with vitamin K antagonists such as warfarin. Hemopericardium is a life-threatening ble...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1602

    authors: Sigawy C,Apter S,Vine J,Grossman E

    更新日期:2015-07-01 00:00:00

  • Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease.

    abstract::The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the evaluation, classification, and stratification of chronic kidney disease (CKD). These guidelines provide, for the first...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.25.4.491.61034

    authors: Bailie GR,Uhlig K,Levey AS

    更新日期:2005-04-01 00:00:00

  • Retrospective analysis of hyperlipidemia management in a transplant population.

    abstract:STUDY OBJECTIVES:To determine the prevalence of hyperlipidemia and the effectiveness of hyperlipidemia management in a large population of transplant recipients. A secondary objective was to assess the effect of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III guidelines on hyperlipidemia man...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.7.918

    authors: Schonder KS,McKaveney TP,Lynch KJ

    更新日期:2005-07-01 00:00:00

  • Principles of drug literature evaluation for observational study designs.

    abstract::Clinical pharmacists must often interpret and use data derived from observational studies when making clinical decisions and recommendations, answering drug information questions, and educating patients about drug therapy. This is the third article in a three-part series intended to enhance clinical pharmacists' under...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.2.115

    authors: Shields KM,DiPietro NA,Kier KL

    更新日期:2011-02-01 00:00:00

  • Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.

    abstract::Rapacuronium is a new steroidal, nondepolarizing, neuromuscular blocking agent. It appears to be the least potent of all available nondepolarizing muscle relaxants. Its onset of action resembles that of succinylcholine, and its recovery times are shorter than those of other nondepolarizing agents. The clinical duratio...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.15.1118.30572

    authors: Larijani GE,Zafeiridis A,Goldberg ME

    更新日期:1999-10-01 00:00:00

  • Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin.

    abstract::Serious gram-positive infections present an increasingly common therapeutic dilemma. Combination antimicrobial regimens (e.g., linezolid with rifampin) aimed at improving bacterial eradication and preventing resistance are often used; however, most data supporting this treatment strategy are not from randomized contro...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.3.476

    authors: Gebhart BC,Barker BC,Markewitz BA

    更新日期:2007-03-01 00:00:00

  • Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation.

    abstract::Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with thromboembolic events and hemodynamic impairment that results in considerable morbidity, mortality, and cost. Cardioversion to sinus rhythm is a common approach to the treatment of these patients. However, cardioversion is assoc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.23.1.57.31917

    authors: Wodlinger AM,Pieper JA

    更新日期:2003-01-01 00:00:00